Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management
Bernice Tsoi,1,2 Gord Blackhouse,1,2 Simon Ferrazzi,3 Clare J Reade,4 Innie Chen,5,6 Ron Goeree1,2,7 1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; 2Programs for Assessment of Technology in Health (PATH) Research Institute, St Joseph's Heal...
Main Authors: | Tsoi B, Blackhouse G, Ferrazzi S, Reade CJ, Chen I, Goeree R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/incorporating-ulipristal-acetate-in-the-care-of-symptomatic-uterine-fi-peer-reviewed-article-CEOR |
Similar Items
-
Effects of ulipristal acetate in patients with symptomatic uterine fibroids
by: Natalia Navarro Plazaola, et al.
Published: (2021-05-01) -
Ulipristal acetate in uterine fibroids treatment
by: V V Korennaya, et al.
Published: (2013-12-01) -
Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
by: Trefoux Bourdet A, et al.
Published: (2015-03-01) -
The effect of ulipristal acetate treatment on symptomatic uterine fibroids within 12-months follow-up
by: Sławomir Woźniak, et al.
Published: (2014-03-01) -
Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
by: Javier Monleón, et al.
Published: (2014-01-01)